Global Non-Sterile Compounding Pharmacy Market Growth (Status and Outlook) 2023-2029

Global Non-Sterile Compounding Pharmacy Market Growth (Status and Outlook) 2023-2029

Nonsterile drug compounding is the practice of preparing specific medication doses for patients to drink, swallow, insert or apply to the skin. It is the most common kind of drug compounding done by pharmacists and pharmacy technicians in community and hospital pharmacies. And despite its "nonsterile" designation, making customized dosages according to legal and professional standards requires adhering to strict rules for ensuring and maintaining active pharmaceutical ingredient purity and potency; ensuring the accuracy of mixing; providing proper packaging, storage, and labeling; and keeping all work surfaces and equipment as clean as possible.

LPI (LP Information)' newest research report, the “Non-Sterile Compounding Pharmacy Industry Forecast” looks at past sales and reviews total world Non-Sterile Compounding Pharmacy sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-Sterile Compounding Pharmacy sales for 2023 through 2029. With Non-Sterile Compounding Pharmacy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Sterile Compounding Pharmacy industry.

This Insight Report provides a comprehensive analysis of the global Non-Sterile Compounding Pharmacy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Sterile Compounding Pharmacy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Sterile Compounding Pharmacy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Sterile Compounding Pharmacy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Sterile Compounding Pharmacy.

The global Non-Sterile Compounding Pharmacy market size is projected to grow from US$ 594.1 million in 2022 to US$ 690.8 million in 2029; it is expected to grow at a CAGR of 2.2% from 2023 to 2029.

Simple nonsterile compounding involves mixing medications according to established formulas, or "recipes," and creating liquid versions of drugs usually sold only as tablets or capsules. Pediatricians and veterinarians often request these kinds of products for babies and animals who cannot swallow pills or need doses smaller than ones in commercially produced products. Moderate nonsterile compounding involves making dosages containing potentially harmful medications or preparations that require special handling.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-Sterile Compounding Pharmacy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Oral Medication
Topical Medications
Otologic/Nasal Medication

Segmentation by application
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Fagron
B.Braun Melsungen
Fresenius Kabi
True Nature Holding
Dougherty's Pharmacy
Pharmedium

Please note: The report will take approximately 2 business days to prepare and deliver.